Barcelona-based biotech innovator Algaktiv has launched Exometics G, a breakthrough biomimetic exosome technology derived entirely from microalgae—marking a major leap forward in ethical, high-performance skincare. Engineered for precision and potency, Exometics G delivers over 10 billion vesicles per milliliter, allowing beauty brands to boast more than 10 million exosomes per drop.
With a tightly controlled particle size of 150 nanometers, this active ensures optimal skin absorption and efficacy in renewal, elasticity, and anti-aging. 100% vegan, cruelty-free, and lab-grown using patented technology, Exometics G circumvents the ethical and regulatory hurdles of animal- or human-derived exosomes while offering a sustainable, scalable solution with unmatched consistency.
"Exometics G overcomes the limitations of traditional exosomes, providing a standardized, high-potency alternative," said Jordi Ayats, product director at Algaktiv.
Image Credit: JLco Julia Amaral
What's Driving This Trend
- Vegan Biomimetic Exosomes
- This innovation offers a plant-based alternative to animal-derived exosomes, catering to ethical and sustainable beauty demands.
- Precision Skincare Delivery
- The use of precisely engineered vesicles in skincare allows for enhanced absorption and targeted results in skin renewal.
- Scalable Lab-grown Actives
- Lab-grown technologies pave the way for scalable production of high-consistency skincare actives, eliminating reliance on natural sources.
Who This Affects Most
- Biotech Skincare
- Biotech-driven skincare formulations leverage advanced biology to address consumer needs for effective and ethical beauty products.
- Sustainable Beauty
- Sustainability-focused beauty products are gaining traction as consumers increasingly demand eco-friendly and cruelty-free options.
- Cosmetic Nanotechnology
- The application of nanotechnology in cosmetics introduces precision active delivery systems that enhance product performance.
